For GLP-1 therapies, switching to a reusable device can lead to a waste reduction of up to 96% and a CO 2 reduction of 94%, further amplifying the environmental benefits (Ypsomed, internal data on file, 2024
Thibault te conseille et taide trouver les produits adapts ton obejctif +33 06 29 93 11 66 Soldes d't
Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease
Additive benefits of combined GLP-1/SGLT2 therapy on other metabolic parameters, including HbA1c, weight loss and MASH, all can be expected
Yes, fatigue is a fairly common side effect of semaglutide, though the causes are usually manageable
No clinical evidence shows that GLP-1 receptor agonists damage or stress the remaining bile ducts or liver after cholecystectomy